Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder

NCT01945489 is registered in ClinicalTrials.gov with Allergan as lead sponsor.

NCT NCT01945489
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01945489 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
Lead sponsor
Allergan
Phase
Phase 4
Overall status
Completed
Start date
October 28, 2013
Completion date
January 5, 2017
Enrollment
254 (actual)
Sites
40

Conditions

As the registry lists them; a condition with its own page is linked.

overactive bladder